Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anti allergic/diarrhea

Koblingen er lagret på utklippstavlen
Side 1 fra 18 resultater

Indole-2-alkanoic acids compositions of and anti allergic use thereof

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
SUMMARY OF THE INVENTION This invention relates to prostaglandin antagonists useful in treating a variety of conditions, such as allergic asthma where excessive contractile activity of prostaglandins and prostaglandin biosynthetic intermediates occur. These compounds antagonize the actions of

Heterocycle-fused morphinans, use thereof and preparation thereof

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD The present disclosure relates to certain heterocycle fused morphianans. Compounds of the present disclosure are mixed mu agonist delta antagonists or dual mu agonist/delta agonists or antagonists at mu, delta and kappa opioid receptors. Compounds of the present disclosure are useful

Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION The leukotrienes and their biological activities, especially their role in various disease states, have been extensively studied. Their properties are described in the book Leukotrienes and Lipoxygenases, Ed., J. Rokach, Elsevier, N.Y., 1989. Inhibitors of the

Dibenzoheterocyclic hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION The leukotrienes and their biological activities, especially their role in various disease states, have been extensively studied. Their properties are described in the book Leukotrienes and Lipoxygenase, Ed., J. Rokach, Elsevier, N.Y., 1989. Inhibitors of the

(Quinolin-2-ylmethoxy)indole/cyclodextrin complex

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION EP 419,049, Prasit et al., Mar. 27, 1991, describes a series of quinolin-2-ylmethoxy indoles useful as inhibitors of leukotriene biosynthesis. Examples 1 and 1A therein teach the synthesis of 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-

(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing

(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing

Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing

(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing

Fluorinated quinoline indoles as inhibitors of the biosynthesis of leukotrienes

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
CROSS REFERENCE The compounds of Formula I' are described in U.S. Ser. No. 650,825 filed Feb. 5, 1991, which is now U.S. Pat. No. 5,204,344, and incorporated herein by reference. BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds

Amorphous (quinolin-2-ylmethoxy)indole compounds which have useful pharmaceutical utility

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION EP 419,049, Prasit et al., Mar. 27, 1991, describes a series of quinolin-2-ylmethoxy indoles useful as inhibitors of leukotriene biosynthesis. Examples 1 and 1A therein teach the synthesis of 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-

Amorphous (quinolin-2-ylmethoxy)indole compounds useful for treating inflammatory diseases

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION EP 419,049, Prasit et al., Mar. 27, 1991, describes a series of quinolin-2-ylmethoxy indoles useful as inhibitors of leukotriene biosynthesis. Examples 1 and 1A therein teach the synthesis of 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-

(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing

(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing

(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION European Patent Applications 166,591 and 275,667 disclose a series of indole-based compounds with activity as prostaglandin antagonists and inhibitors of leukotriene biosynthesis respectively. In EP 181,568 and EP 200,101 are disclosed a series of compounds, containing
Bli med på
facebooksiden vår

Den mest komplette databasen med medisinske urter støttet av vitenskap

  • Fungerer på 55 språk
  • Urtekurer støttet av vitenskap
  • Urtegjenkjenning etter bilde
  • Interaktivt GPS-kart - merk urter på stedet (kommer snart)
  • Les vitenskapelige publikasjoner relatert til søket ditt
  • Søk medisinske urter etter deres effekter
  • Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter

Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning

Google Play badgeApp Store badge